(Q38111096)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Immune modulation by genetic modification of dendritic cells with lentiviral vectors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Grazyna Kochan

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

David Guerrero-Setas

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Karine Breckpot

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Therese Liechtenstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Noemi Perez-Janices

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Christopher Bricogne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Alessio Lanna

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Inès Dufait

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Roberta Laranga

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Antonella Padella

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Frederick Arce

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Mehdi Baratchian

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Natalia Ramirez

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Natalia Lopez

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Idoia Blanco-Luquin

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

David Escors

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

28 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

1-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23726846%20AND%20SRC:MED&resulttype=core&format=json

ERK1-/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis.

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Targeting lentiviral vectors for cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Selective activation of intracellular signalling pathways in dendritic cells for cancer immunotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Anti-inflammatory properties of Type I interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Insertional gene activation by lentiviral and gammaretroviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Human tumor antigens recognized by T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Attenuated Expression of A20 Markedly Increases the Efficacy of Double-Stranded RNA-Activated Dendritic Cells As an Anti-Cancer Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Lentivirally transduced dendritic cells as a tool for cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Activation of Immature Monocyte-Derived Dendritic Cells After Transduction with High Doses of Lentiviral Vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

DNA fusion vaccine designs to induce tumor-lytic CD8+ T-cell attack via the immunodominant cysteine-containing epitope of NY-ESO 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

CD4 T cells integrate signals delivered during successive DC encounters in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Cbl-b regulates the CD28 dependence of T-cell activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Interferon-beta treatment alters peripheral blood monocytes chemokine production in MS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

CD8 T Cell Clonal Expansion and Development of Effector Function Require Prolonged Exposure to Antigen, Costimulation, and Signal 3 Cytokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Structural basis for cooperative RNA binding and export complex assembly by HIV Rev

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Expression of tumour-specific antigens underlies cancer immunoediting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Lentiviral vectors in gene therapy: their current status and future potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Targeting dendritic cell signaling to regulate the response to immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

A new-generation stable inducible packaging cell line for lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

HIV-1 tat trans-activation requires the loop sequence within tar.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Restoring the balance: Harnessing regulatory T cells for therapy in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Regulatory T cells and tumour immunity - observations in mice and men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Lymphomagenesis in SCID-X1 mice following lentivirus-mediated phenotype correction independent of insertional mutagenesis and gammac overexpression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Conventional dendritic cells are required for the activation of helper-dependent CD8 T cell responses to a model antigen after cutaneous vaccination with lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Targeting of Toll-like receptors: a decade of progress in combating infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Dendritic cells genetically engineered to express IL-10 induce long-lasting antigen-specific tolerance in experimental asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Adoptive transfer of siRNA Cblb-silenced CD8+ T lymphocytes augments tumor vaccine efficacy in a B16 melanoma model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Control of regulatory T cell development by the transcription factor Foxp3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Continuous high-titer HIV-1 vector production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Toll-like receptor control of the adaptive immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Efficient gene targeting mediated by a lentiviral vector-associated meganuclease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Characterization of ribosomal frameshifting in HIV-1 gag-pol expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Tumour-mediated disruption of dendritic cell function: inhibiting the MEK1/2-p44/42 axis restores IL-12 production and Th1-generation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Signals and signs for lymphocyte responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

PD-L1 co-stimulation, ligand-induced TCR down-modulation and anti-tumor immunotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

7 January 2021

The retroviral enzymes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Toll-like receptor and RIG-I-like receptor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Interleukin-10-deficient mice develop chronic enterocolitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Gene transfer in humans using a conditionally replicating lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

On the dynamics of TCR:CD3 complex cell surface expression and downmodulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Patient monitoring and follow-up in lentiviral clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

High-throughput retroviral tagging to identify components of specific signaling pathways in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Cancer regression in patients after transfer of genetically engineered lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

The growing family of interferon regulatory factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Blockade of MEK/ERK signaling enhances sunitinib-induced growth inhibition and apoptosis of leukemia cells possessing activating mutations of the FLT3 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Constitutive mutant and putative regulatory serine phosphorylation site of mammalian MAP kinase kinase (MEK1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Toll-dependent control mechanisms of CD4 T cell activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Ipilimumab: attenuation of an inhibitory immune checkpoint improves survival in metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Myeloid-derived suppressor cell heterogeneity and subset definition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Blockade of programmed death ligand 1 enhances the therapeutic efficacy of combination immunotherapy against melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Toll-like receptors and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Expression of vFLIP in a lentiviral vaccine vector activates NF-{kappa}B, matures dendritic cells, and increases CD8+ T-cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Regulatory T cells and immune tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Therapeutic intervention in cancer and chronic viral infections: antibody mediated manipulation of PD-1/PD-L1 interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

CD28, CTLA-4 and their ligands: who does what and to whom?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Regulation of type I interferon gene expression by interferon regulatory factor-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

rDNA-directed integration by an HIV-1 integrase--I-PpoI fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Cbl-b regulates antigen-induced TCR down-regulation and IFN-gamma production by effector CD8 T cells without affecting functional avidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Kaposi's sarcoma-associated herpesvirus vFLIP and human T cell lymphotropic virus type 1 Tax oncogenic proteins activate IkappaB kinase subunit gamma by different mechanisms independent of the physiological cytokine-induced pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Syk-dependent ERK activation regulates IL-2 and IL-10 production by DC stimulated with zymosan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Taking dendritic cells into medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Identification of genes involved in growth autonomy of hematopoietic cells by analysis of factor-independent mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Morphological transformation induced by activation of the mitogen-activated protein kinase pathway requires suppression of the T-type Ca2+ channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

New genes involved in cancer identified by retroviral tagging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

T-cell receptor gene therapy for cancer: the progress to date and future objectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Gene therapy: X-SCID transgene leukaemogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Lentiviral vectors: turning a deadly foe into a therapeutic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

T cell defined tumor antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Engineering targeted viral vectors for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Silencing of the TGF-β1 gene increases the immunogenicity of cells from human ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Induction of myeloid-derived suppressor cells by tumor exosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Effective gene therapy with nonintegrating lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

The role of the p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and phosphoinositide-3-OH kinase signal transduction pathways in CD40 ligand-induced dendritic cell activation and expansion of virus-specific CD8+ T cell m

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007

inferred from DOI database lookup

7 January 2021

based on heuristic

A third-generation lentivirus vector with a conditional packaging system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.05.007